Clinical and Hematological Features of 335 Patients of Chronic Myelogenous Leukemia Diagnosed at Single Centre in Northern Pakistan by F.A. Bhatti, S. Ahmed, N. Ali

“…There are no studies regarding analysis of clinical and haematological features of chronic myelogenous leukemia (CML) from Pakistan. This study analyzes the data of patients suffering from CML, reporting to a major referral Institute in Northern Pakistan in the past 6 years and 3 months. …”
Get full text

Relationship of an hRAD54 gene polymorphism (2290 C/T) in an Ecuadorian population with chronic myelogenous leukemia by César Paz-y-Miño, Andrés López-Cortés, María José Muñoz, Bernardo Castro, Alejandro Cabrera, María Eugenia Sánchez

“…Additionally, we dissected the leukemia group in chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL) to evaluate the polymorphism. …”
Get full text

Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after bone marrow transplantation by Castro F.A., Palma P.V.B., Morais F.R., Voltarelli J.C.

Subjects: “…Chronic myelogenous leukemia…”
Get full text

Methyl-Thiol-Bridged Oxadiazole and Triazole Heterocycles as Inhibitors of NF-κB in Chronic Myelogenous Leukemia Cells by Basappa Basappa, Young Yun Jung, Akshay Ravish, Zhang Xi, Ananda Swamynayaka, Mahendra Madegowda, Vijay Pandey, Peter E. Lobie, Gautam Sethi, Kwang Seok Ahn

Subjects: “…chronic myelogenous leukemia cells…”
Get full text

Brassinin Induces Apoptosis, Autophagy, and Paraptosis via MAPK Signaling Pathway Activation in Chronic Myelogenous Leukemia Cells by Min Hee Yang, In Jin Ha, Seok-Geun Lee, Junhee Lee, Jae-Young Um, Gautam Sethi, Kwang Seok Ahn

Subjects: Get full text

“Preleukemic or smoldering” chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report by John M. Bennett, Kevin G. Dsouza, Mehul Patel, Kristen O’Dwyer

“…Chronic myelogenous leukemia (CML), in the Chronic Phase (CP), is often suspected as a result of a complete blood count (CBC), which shows increased granulocytes, mostly mature including a peak in myelocytes, increased basophils, and rarely blasts and/or promyelocytes. …”
Get full text

A novel enhancer RNA, Hmrhl, positively regulates its host gene, phkb, in chronic myelogenous leukemia by Roshan Fatima, Subhendu Roy Choudhury, Divya T.R, Utsa Bhaduri, M.R.S. Rao

“…Analysis of Hmrhl locus using ENCODE database revealed that it exhibits hallmarks of enhancers like the open chromatin configuration, binding of transcription factors, enhancer specific histone signature etc. in the K562 Chronic Myelogenous Leukemia (CML) cells. We compared the expression of Hmrhl in the normal lymphoblast cell line, GM12878, with that of K562 cells and lymphoma samples and show that it is highly upregulated in leukemia as well as several cases of lymphoma. …”
Get full text

Which Tyrosine Kinase Inhibitors Should Be Selected as the First-Line Treatment for Chronic Myelogenous Leukemia in Chronic Phase? by Takaaki Ono

Subjects: “…chronic myelogenous leukemia…”
Get full text

Isolated blast crisis relapse in the central nervous system of a patient treating for a chronic myelogenous leukemia by Houda Boudiaf, Khedaoudj Ezziane, Nassiba Ould Rouis, Meriem Himrane, Saliha Hakem, Hanifa Benchabane, Houria Boukhelal, Radja Arous, Lynda Chikhi

Get full text

Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells by Yan Xu, Satoshi Ikeda, Kentaro Sumida, Ryusuke Yamamoto, Hiroki Tanaka, Nagahiro Minato

“…Chronic myelogenous leukemia (CML)-initiating cells are resistant to kinase inhibitors. …”
Get full text

Human Telomerase Reverse Transcriptase (hTERT) expression in patients with Chronic Myelogenous Leukemia at defferent phases of the disease by A Amini, SH Ghaffari, Y Mortazavi, N Eynolahi, K Alimoghadam, Sh Rostami, Y Gahani, A Ghavamzadeh

“…Background and Aim: Chronic Myelogenous Leukemia (CML) is a clonal hematopoietic stem cell disorder characterized by a translocation between chromosome 9 and 22 called Philadelphia Chromosome. …”
Get full text

Clinical Importance of Drug Adherence during Tyrosine Kinase Inhibitor Therapy for Chronic Myelogenous Leukemia in Chronic Phase by Yasuhiro Maeda, Atsushi Okamoto, Kenta Yamamoto, Go Eguchi, Yoshitaka Kanai

Get full text

DNA self-assembly nanoflower reverse P-glycoprotein mediated drug resistance in chronic myelogenous leukemia therapy by Pengxuan Zhao, Yeteng Zhong, Pengcheng Pan, Shasha Zhang, Shasha Zhang, Yu Tian, Yu Tian, Jun Zhang, Guohui Yi, Zhendong Zhao, Tiantian Wu

Subjects: Get full text

Human Telomerase Reverse Transcriptase (hTERT) Expression in Patients with Chronic Myelogenous Leukemia at Different Phases of the Disease by K Alimoghadam, N Eynolahi, Y Mortazavi, Sh Rostami, SH Ghaffari, A Amini, Y Gahani, A Ghavamzadeh

“…Background and Aim: Chronic Myelogenous Leukemia (CML) is a clonal hematopoietic stem cell disorder characterized by a translocation between chromosome 9 and 22 called Philadelphia Chromosome. …”
Get full text

Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells by Seiichi Okabe, Akihiko Gotoh

Get full text

Correction: Real-Time Analysis of Imatinib- and Dasatinib-Induced Effects on Chronic Myelogenous Leukemia Cell Interaction with Fibronectin.

Get full text

ROLE OF BREAK CLUSTER REGION (BCR) - ABELSON MURINE LEUKIMIA (ABL) EXAMINATION IN CHRONIC MYELOGENOUS LEUKEMIA (CML) by Agung Sosiawan

“…As myeloproliferative disease, Chronic Myelogenous Leukemia or CML is a malignancy of the sixth-highest, reaching 15% of all blood malignancies in adults with an incidence of 1.1 per 100,000 population (Ugroseno, 2012). …”
Get full text

Gender and ethnic differences in chronic myelogenous leukemia prognosis and treatment response: a single-institution retrospective study by Masiello David, Birnstein Elliott, Lee Justin P, Yang Dongyun, Yang Allen S

“…Our study was undertaken to examine the demographic and clinical features of chronic myelogenous leukemia (CML) patients presenting initially at the LAC+USC Medical Center, which serves an ethnically diverse population.…”
Get full text

Correction: Real-Time Analysis of Imatinib- and Dasatinib-Induced Effects on Chronic Myelogenous Leukemia Cell Interaction with Fibronectin

Get full text

Nilotinib cause moyamoya disease in the treatment of chronic myelogenous leukemia during chronic phase: A case report by Jin-ping Liang, Rui-hua Mi, Lin Chen, Xu-dong Wei

Subjects: Get full text